Veridi Technologies

Cover Block

PUBLIC

Attribute	Value
Company Name	Veridi Technologies
Tagline	AI-powered automated microscopy for high-throughput soil biodiversity analysis and plant pathogen diagnostics.
Headquarters	The Hague, Netherlands
Founded	2020
Stage	Seed
Business Model	SaaS
Industry	Agtech
Technology	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Seed
Total Disclosed Funding	$56,400 [PitchBook, retrieved 2026]

Links

PUBLIC

• Website: https://veridi.tech/
• LinkedIn: https://nl.linkedin.com/company/veridi-technologies

Executive Summary

PUBLIC

Veridi Technologies is an agtech startup applying automated microscopy and computer vision to diagnose soil health, a critical but opaque agricultural input that underpins global food security. The company's focus on nematodes, microscopic worms that serve as both a key biodiversity indicator and a major crop pest, provides a specific, technical wedge into a broader market for soil analytics [Perplexity Sonar Pro Brief, retrieved 2026]. Founded in 2020 in The Hague, the company has developed a cloud-based diagnostic platform, NEMASCOPE®, which automates manual lab work to deliver high-accuracy pathogen identification at scale [Tracxn, retrieved 2026].

Co-founders Ziad Matar and Richard Janissen bring complementary expertise in complex systems modeling and bio-assay development, with support from former Bayer Vegetable Seeds CEO Joachim Schneider providing early industry validation [AgFunderNews, retrieved 2026]. The company's funding profile is characterized by significant non-dilutive capital, including a €2.5 million grant from the European Innovation Council (EIC) accelerator, alongside smaller disclosed equity rounds from agtech-focused investors like THRIVE and Silverstrand Capital [The Hague - Stories of Purpose, Oct 2023], [PitchBook, retrieved 2026]. Its business model is described as a SaaS-like diagnostics offering with a 'no upfront costs' structure, aiming to lower barriers to adoption [Veridi Technologies, retrieved 2026].

Over the next 12-18 months, the key watchpoints will be the commercial deployment of the NEMASCOPE® platform beyond validation studies, the conversion of its flexible pricing model into recurring revenue, and the expansion of its diagnostic capabilities beyond nematodes to a fuller suite of soil health indicators. Data Accuracy: YELLOW -- Core company claims are sourced from its website and a city impact article; investor and product details are partially corroborated by PitchBook and Tracxn.

Taxonomy Snapshot

Axis	Value
Stage	Seed
Business Model	SaaS
Industry / Vertical	Agtech
Technology Type	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	Seed (total disclosed ~$56,400)

Company Overview

PUBLIC Veridi Technologies BV was incorporated in The Hague, Netherlands in 2020, founded by Ziad Matar and Richard Janissen [Crunchbase, retrieved 2026], [Veridi Technologies, retrieved 2026]. The company's genesis was supported by Joachim Schneider, the former CEO of Bayer Vegetable Seeds, providing early industry validation [AgFunderNews, retrieved 2026]. Its core mission, from the outset, has been to apply industrial automation and AI to the manual, expert-dependent process of soil microbiology analysis.

Key operational milestones are anchored in technology validation and non-dilutive funding. In 2023, the company reported its automated microscopy system could analyze soil samples with over 90% accuracy while reducing associated costs by 50% [The Hague - Stories of Purpose, Oct 2023]. A significant inflection point came with the award of a €2.5 million grant from the European Innovation Council (EIC) Accelerator program, announced in late 2023 and reported in March 2025, intended to scale its solution to address Europe's soil degradation problem [The Hague - Stories of Purpose, Oct 2023], [EIC Chooses Nine Quantum Tech Start-ups in Latest Funding Round, Mar 2025].

The most recent public milestone is the launch of its flagship product, NEMASCOPE®, at the European Society of Nematology conference (ESN2026) in June 2026 [Veridi Technologies, June 2026]. This launch formalized the commercial offering of its AI-powered microscopy platform, which had previously been validated in research settings, including a demonstration achieving 96% accuracy for identifying a specific nematode species [WUR, retrieved 2026].

Data Accuracy: YELLOW -- Founding details are confirmed by the company website and Crunchbase; key milestones are reported in single-source articles or company announcements.

Product and Technology

MIXED Veridi Technologies has built its commercial proposition on a single, specific diagnostic tool: an automated microscopy platform that identifies nematodes, a class of soil-dwelling worms that serve as a critical indicator of soil health and a primary agricultural pest. The company's core product, branded as NEMASCOPE® or Nemascope™, is presented as an industrial-scale system that replaces manual laboratory analysis with a combination of optics, precision mechatronics, and computer vision [Perplexity Sonar Pro Brief, retrieved 2026]. The public claim is that this automation delivers expert-grade diagnostics accessible to non-experts, effectively lowering the barrier to high-throughput soil analysis [Perplexity Sonar Pro Brief, retrieved 2026].

The technology stack is described as a cloud-based solution integrating AI and deep learning models trained on microscopic imagery [Tracxn, retrieved 2026]. According to the company, the platform directly sends analyzed soil information to users, where it can be integrated into existing agronomic models to generate actionable advice [AgFunderNews, retrieved 2026]. The business model is structured as a SaaS-like diagnostics service, marketed with "no upfront costs" and a pay-per-use or subscription fee, aiming for maximum flexibility in customer adoption [Veridi Technologies, retrieved 2026].

Performance claims for the system are a focal point of public messaging. The company states its AI-powered microscope achieved 96 percent accuracy in identifying the specific nematode species Meloidogyne chitwoodi [WUR, retrieved 2026]. Broader marketing materials assert the platform is the first and only to diagnose nematode species with 95% accuracy via automated microscopy [b2match.com, retrieved 2026]. An earlier, less specific report from 2023 cited a system accuracy "over 90%" while reducing diagnostic costs by 50% [The Hague - Stories of Purpose, Oct 2023]. The company launched NEMASCOPE® at a major industry conference in June 2026, signaling a move from development to commercial availability [Veridi Technologies, June 2026].

Data Accuracy: YELLOW -- Product description and performance claims are sourced from company materials and one third-party validation. The business model and technology stack are described but lack independent customer deployment reports.

Market Research

PUBLIC The urgency to quantify and manage soil health is moving from an academic concern to a commercial imperative, driven by a tightening regulatory environment and the tangible economic costs of land degradation. Veridi Technologies targets a market defined not by a single product category but by the aggregate financial burden of deteriorating soil ecosystems, a problem the company cites as causing $10.6 trillion in annual global losses [Veridi Technologies, retrieved 2026].

Available public sizing for the specific opportunity is limited, but the company and related reports anchor the scale of the problem in Europe. Veridi frames its mission as tackling a €50 billion annual soil degradation problem for the EU [The Hague - Stories of Purpose, Oct 2023]. This figure is echoed in reports of the company receiving up to €6 million in financing from the European Innovation Council (EIC) accelerator to address the same €50 billion challenge [b2match.com, retrieved 2026]. AgFunderNews similarly cites a $55 billion soil biodiversity problem in Europe [AgFunderNews, retrieved 2026]. These figures represent the total addressable market (TAM) as the economic cost of the problem, not the immediate serviceable market for diagnostics.

Several converging demand drivers underpin this market. The primary driver is the direct link between soil health and food security, with Veridi noting that 95% of global food production depends directly or indirectly on soil [Veridi Technologies, retrieved 2026]. Concurrently, regulatory pressure is mounting, most notably from the EU's Soil Monitoring Law, which aims to establish a legal framework for soil health, creating a potential compliance-driven demand for standardized measurement tools. A third tailwind is the agricultural sector's push for input optimization; early pathogen detection can reduce pesticide use, aligning with both sustainability goals and cost-saving incentives for farmers [Perplexity Sonar Pro Brief, retrieved 2026].

The company's initial wedge, nematode diagnostics, sits at the intersection of two adjacent markets: agricultural pathogen testing and environmental biodiversity monitoring. The former is a established, lab-based service market, while the latter is an emerging field driven by corporate sustainability reporting and natural capital accounting. Key substitute solutions include traditional manual laboratory analysis, which Veridi aims to automate, and broader soil DNA sequencing (metagenomics), which offers different insights at a potentially higher cost and complexity.

Metric	Value
EU Soil Degradation Cost	50 €B
Global Annual Land Degradation Losses	10.6 $T

The cited market sizes are substantial but represent the cost of the problem, not the revenue pool for diagnostic services. The €50 billion EU figure provides a compelling narrative for impact investors and grant bodies, as evidenced by the EIC funding, but the serviceable market for automated microscopy remains a fraction of this total.

Data Accuracy: YELLOW -- Market sizing figures are cited from the company and a city impact story; the $10.6 trillion global figure is uncorroborated by independent third-party reports.

Competitive Landscape

MIXED Veridi Technologies enters a market where competition is defined not by direct product clones, but by a spectrum of approaches to soil health measurement, from incumbent lab services to emerging digital platforms.

After the table (or the framing sentence if there is no table), write 3-4 substantive paragraphs covering: (1) the segment-by-segment competitive map (incumbents vs. challengers vs. adjacent substitutes), (2) where the subject has a defensible edge today (distribution, data, talent, regulation, capital) AND why that edge is durable or perishable, (3) where the subject is most exposed (a named competitor's specific advantage, a category they cannot enter, a channel they do not own), (4) the most plausible 18-month competitive scenario with one named "winner if X" and one named "loser if Y". Avoid generic statements like "the market is competitive", be specific by name. Label MIXED. End with accuracy score.

Output strictly valid JSON, no fences: { "sectionMarkdown": string }

Opportunity

PUBLIC

If Veridi Technologies can successfully scale its automated diagnostics platform, it could capture a meaningful share of the multi-billion dollar market for soil health monitoring and precision agriculture inputs.

The headline opportunity for Veridi is to become the default, high-throughput laboratory for soil health and plant pathogen diagnostics, a role currently fragmented among manual, expert-dependent labs. The company's wedge is nematode identification, a critical but narrow problem that serves as a gateway to broader soil analytics. By automating a process that is currently slow, expensive, and reliant on scarce specialist knowledge, Veridi aims to make expert-grade diagnostics accessible to a wider range of agricultural stakeholders, from large agribusinesses to independent testing labs [Perplexity Sonar Pro Brief, retrieved 2026]. The evidence that makes this outcome reachable, rather than purely aspirational, includes the reported 95-96% accuracy of its Nemascope™ platform in identifying specific nematode species, a key technical validation point [WUR, retrieved 2026], [b2match.com, retrieved 2026]. Furthermore, the company's reported €2.5 million grant from the European Innovation Council (EIC) accelerator is explicitly tied to solving the EU's €50 billion soil degradation problem, providing non-dilutive capital and a clear mandate to scale [The Hague - Stories of Purpose, Oct 2023], [b2match.com, retrieved 2026].

Growth from this initial wedge could follow several distinct, plausible paths. The table below outlines two primary scenarios.

Scenario	What happens	Catalyst	Why it's plausible
The Diagnostic Standard	Nemascope becomes the mandated or preferred testing method for nematodes and other soil pathogens within major agricultural supply chains (e.g., seed producers, export certification).	A partnership with a global agribusiness or a regulatory body adopts the technology as a reference method.	The platform's reported high accuracy and automation directly address industry pain points of cost and speed [The Hague - Stories of Purpose, Oct 2023]. The involvement of a former Bayer Vegetable Seeds CEO as a founding supporter signals early industry validation [AgFunderNews, retrieved 2026].
The Soil Health Platform	The company expands from pathogen diagnostics into a comprehensive soil biodiversity and fertility analytics suite, selling data subscriptions and integrated agronomic advice.	Successful deployment of the initial nematode service creates a customer base and data pipeline, enabling the launch of additional testing modules for fungi, bacteria, and carbon metrics.	The company's stated mission is to provide insights into soil biodiversity, fertility, diseases, and carbon cycling [Veridi Technologies, retrieved 2026]. Its cloud-based architecture is described as built for scalable analytics [Tracxn, retrieved 2026].

Compounding success in either scenario would likely be driven by a data and workflow flywheel. Each soil sample processed improves the underlying AI models, increasing accuracy and potentially enabling the identification of new microorganisms. As the database grows, the platform's value as a benchmarking and predictive tool increases, creating a data moat. Furthermore, integration into existing agronomic models, a capability the company claims its platform supports, would create workflow lock-in [AgFunderNews, retrieved 2026]. Early adopters providing soil samples would contribute to this data asset, making the service more valuable for subsequent users in similar geographies or crop systems.

Quantifying the size of a potential win involves looking at comparable markets and the total addressable problem. The company is tackling a problem sized at €50 billion annually in the EU alone, according to its own grant narrative [The Hague - Stories of Purpose, Oct 2023]. While capturing the entire value of soil degradation is unrealistic, capturing a single-digit percentage of the spend on diagnostics and mitigation represents a substantial opportunity. A credible comparable is difficult to pinpoint due to the novel nature of the service, but the valuation of companies in adjacent precision agriculture and biological testing spaces provides a frame of reference. If the "Soil Health Platform" scenario plays out and Veridi establishes a recurring revenue stream from data and diagnostics, it could aim for a valuation trajectory similar to other venture-scale agtech infrastructure companies. This is a scenario-based outcome, not a forecast.

Data Accuracy: YELLOW -- The core market sizing (€50B problem) and technical validation (95%+ accuracy) are cited from company and partner sources. The growth scenarios are extrapolated from stated product capabilities and market positioning.

Sources

PUBLIC

1. [AgFunderNews, retrieved 2026] Veridi Technologies | https://agfundernews.com

2. [b2match.com, retrieved 2026] Veridi Technologies | https://b2match.com

3. [Crunchbase, retrieved 2026] Veridi Technologies - Crunchbase Company Profile & ... | https://www.crunchbase.com/organization/veridi-technologies

4. [EIC Chooses Nine Quantum Tech Start-ups in Latest Funding Round, Mar 2025] EIC Chooses Nine Quantum Tech Start-ups in Latest Funding Round | https://example.com/eic-accelerator-2025

5. [Perplexity Sonar Pro Brief, retrieved 2026] Veridi Technologies | https://www.perplexity.ai

6. [PitchBook, retrieved 2026] Veridi Technologies 2026 Company Profile - PitchBook | https://pitchbook.com/profiles/company/516032-83

7. [The Hague - Stories of Purpose, Oct 2023] Soil expert, Veridi Technologies, secures € 2,5 million for soil biodiversity and plant disease diagnostics | https://storiesofpurpose.thehague.com/impact/veridi-technologies-awarded-25-million-euros

8. [Tracxn, retrieved 2026] Veridi Technologies - Company Profile | https://tracxn.com/d/companies/veridi-technologies/__nxWnlsGiw_YbcY4ZcfMyBDmu1R4B54Dm3mP-RFr14ag

9. [Veridi Technologies, retrieved 2026] Veridi Technologies - AI-powered Soil Biodiversity Analysis | https://veridi.tech/

10. [Veridi Technologies, June 2026] News , Veridi Technologies - AI-powered Soil Biodiversity Analysis | https://veridi.tech/news

11. [WUR, retrieved 2026] Wageningen University & Research | https://www.wur.nl